CANEPA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 13.050
NA - Nord America 2.790
AS - Asia 1.832
Continente sconosciuto - Info sul continente non disponibili 411
SA - Sud America 196
AF - Africa 47
OC - Oceania 8
Totale 18.334
Nazione #
IT - Italia 12.712
US - Stati Uniti d'America 2.582
SG - Singapore 633
CN - Cina 413
VN - Vietnam 308
BD - Bangladesh 238
FR - Francia 129
BR - Brasile 114
CA - Canada 89
HK - Hong Kong 79
GB - Regno Unito 54
DE - Germania 38
FI - Finlandia 34
AR - Argentina 33
IN - India 26
IQ - Iraq 22
JP - Giappone 21
JM - Giamaica 20
MX - Messico 20
CR - Costa Rica 15
CO - Colombia 14
EC - Ecuador 13
ID - Indonesia 11
PK - Pakistan 10
NL - Olanda 9
PH - Filippine 9
TT - Trinidad e Tobago 9
CH - Svizzera 8
ES - Italia 8
HN - Honduras 8
NI - Nicaragua 8
RU - Federazione Russa 8
SV - El Salvador 8
CL - Cile 7
GT - Guatemala 7
IE - Irlanda 7
MA - Marocco 7
PR - Porto Rico 7
TN - Tunisia 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
KR - Corea 6
PL - Polonia 6
PY - Paraguay 6
SA - Arabia Saudita 6
TH - Thailandia 6
TR - Turchia 6
UA - Ucraina 6
AU - Australia 5
EE - Estonia 5
EG - Egitto 5
MY - Malesia 5
VE - Venezuela 5
AZ - Azerbaigian 4
KE - Kenya 4
NP - Nepal 4
BB - Barbados 3
BS - Bahamas 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
JO - Giordania 3
OM - Oman 3
PA - Panama 3
SE - Svezia 3
UY - Uruguay 3
AM - Armenia 2
AW - Aruba 2
BE - Belgio 2
BG - Bulgaria 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
IL - Israele 2
IR - Iran 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
FJ - Figi 1
HU - Ungheria 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LC - Santa Lucia 1
LT - Lituania 1
MN - Mongolia 1
Totale 17.914
Città #
Genova 6.227
Genoa 4.032
Vado Ligure 1.043
Rapallo 1.034
Ashburn 514
San Jose 415
Singapore 298
Council Bluffs 153
Lauterbourg 114
Ho Chi Minh City 105
New York 92
Beijing 76
Hong Kong 73
Hanoi 61
Santa Clara 58
Los Angeles 48
Dallas 36
Bordighera 33
Rome 32
Helsinki 28
Milan 28
Naples 27
Phoenix 26
Chicago 23
Boardman 22
North Bergen 22
Frankfurt am Main 21
Tokyo 17
Da Nang 16
Kingston 16
Mexico City 16
St Louis 16
Montreal 14
Queens 14
San Francisco 14
Toronto 14
Newark 13
Orem 13
Baghdad 12
Florence 12
Bologna 11
Brooklyn 11
Buffalo 11
Haiphong 11
Houston 11
Charlotte 10
Denver 10
Palermo 10
San Antonio 10
San José 10
Boston 9
Catania 9
Kansas City 9
Atlanta 8
Brasília 8
Managua 8
São Paulo 8
Tucson 8
Turin 8
Zurich 8
Chennai 7
Las Vegas 7
Philadelphia 7
San Salvador 7
Cleveland 6
Hải Dương 6
Orlando 6
Quito 6
Quảng Ngãi 6
Tampa 6
Tianjin 6
Washington 6
Bari 5
Biên Hòa 5
Cape Coral 5
Detroit 5
Dhaka 5
Dublin 5
Madrid 5
Manchester 5
Miami 5
Nuremberg 5
Padua 5
Paris 5
Providence 5
Sydney 5
Tashkent 5
The Bronx 5
Austin 4
Bogotá 4
Buenos Aires 4
Cardiff 4
Chaguanas 4
Columbus 4
Des Moines 4
Figino 4
Guangzhou 4
Guatemala City 4
Hangzhou 4
Lexington 4
Totale 15.220
Nome #
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 280
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 272
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure 254
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 252
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 234
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 229
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly 227
Using unsupervised learning to determine risk level for left ventricular diastolic dysfunction2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 224
Cancer in chronic heart failure patients in the GISSI-HF trial 220
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 215
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 214
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 213
E / e' ratio and outcome prediction in hypertrophic cardiomyopathy: The influence of outflow tract obstruction 210
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 208
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry 206
Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure 205
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 198
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 198
[Cardiac cell therapy: the puzzle is waiting to be solved] 197
T1 mapping with cardiovascular magnetic resonance: An emerging clinical biomarker 196
Recurrent and residual shunts after patent foramen ovale closure: Results from a long-term transcranial doppler study 195
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction 194
Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. 192
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy 191
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 189
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 188
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 181
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices 177
The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. 174
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. 172
Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation 171
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 170
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 165
Brugada syndrome and syncope: a practical approach for diagnosis and treatment 165
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 163
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. 162
What can we learn from pulmonary function testing in heart failure? 162
Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy 162
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 160
ECHOCARDIOGRAPHIC AND CLINICAL CORRELATES OF SPECIFIC EARLY REPOLARIZATION SUBTYPES ON ELECTROCARDIOGRAM 160
Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy 158
The association between leptin and depressive symptoms is modulated by abdominal adiposity. 157
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). 156
Multiparametric vs. Inferior Vena Cava-Based Estimation of Right Atrial Pressure 156
GENDER DIFFERENCES IN EARLY MANIFESTATIONS OF ARTERIAL STIFFNESS: RESULTS FROM THE SARDINIA PROJECT 155
Human amniotic fluid stem cell secretome protects cardiomyocytes against doxorubicin toxicity 155
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis 153
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 152
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. 151
Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial 151
Linking Heart Failure to Cancer 151
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 151
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 149
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement 149
Coronary and Cardiac Screening In Liver Transplantation Candidets: A Long Journey with Frequent Identification of Moderate and Severe Coronary Artery Disease 147
Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging). 147
The Relationship Between Brain–Heart Autonomic Signaling and Aging: A Gender-Specific Longitudinal Perspective from the Baltimore Longitudinal Study on Aging 147
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 146
Bmi and acute kidney injury post transcatheter aortic valve replacement: Unveiling the obesity paradox 146
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease 143
Diagnostic value of ischemia severity at myocardial perfusion imaging in elderly persons with suspected coronary disease 142
Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device 142
Modes of death and prognostic outliers in chronic heart failure 140
Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study 139
Lower mitochondrial energy production of the thigh muscles in patients with low-normal ankle-brachial index 138
Impact of Central Obesity on the Estimation of Carotid-Femoral Pulse Wave Velocity. 138
Echocardiographic Tissue Characterization Using Radiomics in Patients With Transthyretin-Related Cardiac Amyloidosis 136
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease 136
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 133
Testing longitudinal data for prognostication in ambulatory heart failure patients with reduced ejection fraction. A proof of principle from the GISSI-HF database 131
The impossible quest to make cardiac amyloidosis diagnosis easy 131
Cardiac amyloidosis: a changing epidemiology with open challenges 130
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 129
Sometimes they come back: recurrent noncardiac right-to-left shunt after percutaneous patent foramen ovale closure. 128
[Italian clinical trials on cardiac cell therapy: where we are and where are we going?] 126
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 126
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 125
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 125
Longitudinal Association between Serum Uric Acid and Arterial Stiffness: Results from the Baltimore Longitudinal Study of Aging 124
Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleagues 124
Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis 124
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis 124
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study 120
Pulse wave velocity testing in the Baltimore longitudinal study of aging. 119
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 119
C–REACTIVE PROTEIN AS A PREDICTOR OF INTIMAL MEDIA THICKNESS IN A HEALTHY COMMUNITY DWELLING POPULATION OF A BROAD AGE RANGE 114
Brugada syndrome and syncope: A systematic review 113
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 109
Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials 109
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 107
Pulmonary and cardiac drugs: clinically relevant interactions 107
Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy 104
Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis 104
[Clinical studies of cardiac cell therapy in Italy] 103
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 102
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium–glucose co-transporter 2 inhibitors? 102
Effect of statin treatment on arterial stiffness in individuals with newly-diagnosed Heterozygous Familial Hypercholesterolemia. 100
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 99
Reply: The Barcelona Bio-HF Calculator: A Contemporary Web-Based Heart Failure Risk Score 99
Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: Lessons from the coronavirus disease 2019 lockdown in Italy 99
Totale 15.785
Categoria #
all - tutte 64.993
article - articoli 61.789
book - libri 0
conference - conferenze 3.204
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.016 0 0 0 106 46 108 63 276 83 117 35 182
2022/20231.246 117 119 24 122 193 186 17 88 201 10 152 17
2023/2024780 34 92 17 108 74 108 49 59 51 29 46 113
2024/20252.611 89 174 59 168 362 271 259 430 134 118 253 294
2025/20265.344 576 262 469 463 556 360 791 228 320 515 383 421
2026/20271.877 436 290 456 695 0 0 0 0 0 0 0 0
Totale 18.334